Tumor vaccine adjuvant effect of TLR7 agonist Imiquimod is limited by inducing immusuppressive cells

被引：0
|
作者：
Dang, Yushe [1 ]
Wagner, Wolfgang M. [1 ]
Gad, Ekram [1 ]
Disis, Mary L. [1 ]
机构：
[1] Univ Washington, Seattle, WA 98195 USA
来源：
CANCER RESEARCH | 2011年 / 71卷
关键词：
D O I：
10.1158/1538-7445.AM2011-747
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
747
引用
收藏
页数：2
相关论文
共 50 条
  • [1] The TLR7 agonist Imiquimod promote the immunogenicity of msenchymal stem cells
    Li Zhang
    Dan Liu
    Dan Pu
    Yanwen Wang
    Li Li
    Yanqi He
    Yalun Li
    Lei Li
    Weimin Li
    Biological Research, 48
  • [2] The TLR7 agonist Imiquimod promote the immunogenicity of msenchymal stem cells
    Zhang, Li
    Liu, Dan
    Pu, Dan
    Wang, Yanwen
    Li, Li
    He, Yanqi
    Li, Yalun
    Li, Lei
    Li, Weimin
    BIOLOGICAL RESEARCH, 2015, 48
  • [3] The adjuvant effect of TLR7 agonist conjugated to a meningococcal serogroup C glycoconjugate vaccine
    Donadei, Agnese
    Balocchi, Cristiana
    Mancini, Francesca
    Proietti, Daniela
    Gallorini, Simona
    O'Hagan, Derek T.
    D'Oro, Ugo
    Berti, Francesco
    Baudner, Barbara C.
    Adamo, Roberto
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2016, 107 : 110 - 119
  • [4] BBIQ, a pure TLR7 agonist, is an effective influenza vaccine adjuvant
    Kaushik, Deepender
    Dhingra, Simran
    Patil, Madhuri T.
    Piplani, Sakshi
    Khanna, Varun
    Honda-Okubo, Yoshikazu
    Li, Lei
    Fung, Johnson
    Sakala, Isaac G.
    Salunke, Deepak B.
    Petrovsky, Nikolai
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2020, 16 (08) : 1989 - 1996
  • [5] Imiquimod: A TLR-7 agonist as adjuvant for a recombinant protein cancer vaccine
    Adams, S.
    O'Neill, D.
    Nonaka, D.
    Manches, O.
    Chiriboga, L.
    Siu, K.
    Shao, Y.
    Gnjatic, S.
    Pavlick, A.
    Bhardwaj, N.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [6] The TLR7 Agonist Imiquimod Triggers Immunogenic Cell Death in Cancer Cells
    Shieh, Jeng-Jer
    Huang, Shi-Wei
    ANNALS OF ONCOLOGY, 2017, 28
  • [7] The TLR7 agonist imiquimod as an adjuvant for radiotherapy-elicited in situ vaccination against breast cancer
    Demaria, Sandra
    Vanpouille-Box, Claire
    Formenti, Silvia C.
    Adams, Sylvia
    ONCOIMMUNOLOGY, 2013, 2 (10)
  • [8] Normalization of tumor vasculature by imiquimod: proposal for a new anticancer therapeutic indication for a TLR7 agonist
    Jarosz-Biej Magdalena
    Czapla Justyna
    Ciepła Joanna
    Smolarczyk Ryszard
    Drzyzga Alina
    Sprus-Lipka Dorota
    Pilny Ewelina
    Matuszczak Sybilla
    Cichoń Tomasz
    Cancer Immunology, Immunotherapy, 74 (3)
  • [9] The TLR7 agonist imiquimod enhances the anti-melanoma effects of a recombinant Listeria monocytogenes vaccine
    Craft, N
    Bruhn, KW
    Nguyen, BD
    Prins, R
    Lin, JW
    Liau, LM
    Miller, JF
    JOURNAL OF IMMUNOLOGY, 2005, 175 (03): : 1983 - 1990
  • [10] TLR7 agonist imiquimod modulates experimental autoimmune encephalomyelitis severity
    O'Brien, K.
    Gran, B.
    EUROPEAN JOURNAL OF NEUROLOGY, 2009, 16 : 246 - 246
12345